Phthalocyanine aryl ruthenium complex and its preparation method and application
Technical field
The invention belongs to technical field of pharmaceuticals, it is related to a kind of phthalocyanine aryl ruthenium complex and its preparation method and application.
Background technique
Currently, cis-platinum has become in the world for one of most commonly used 3 kinds of drugs for the treatment of cancer, sell in the year in the U.S.
Volume reaches nearly 500,000,000 dollars.But the use of cis-platinum is there is also there is certain deficiency, it does not have inhibiting effect to certain tumours, and easily
Cross resistance is generated with other platinum preparations.In addition, there are many side effects for cis-platinum, such as renal toxicity, peripheral nerve toxicity, marrow poison
Property, haematics toxicity and emetic etc..Therefore, efficient, low toxicity and the new type antineoplastic medicine one without cross resistance are found
It is directly the research hotspot of researcher.
Aryl ruthenium complex since its toxicity is low, the high feature of anti-tumor activity and be concerned by people.Porphyrin
Object is closed to attract people's attention since it stablizes nontoxic property and its good luminescent properties.With porphyrins aryl ruthenium
Complex-bound obtains porphyrin and connects aryl ruthenium ruthenium compound, due to the synergistic effect of aryl ruthenium and porphyrin compound, can make it
Have phototoxicity on the basis of having good anti-tumor activity, achievees the effect that enhance its cell inhibitory activity.
Summary of the invention
It is excellent it is an object of the invention to solve at least the above problems and/or defect, and provide at least to will be described later
Point.
The present invention separately has a purpose to be to provide a kind of phthalocyanine aryl ruthenium complex.
A further object of the present invention is to provide a kind of preparation method of phthalocyanine aryl ruthenium complex.
It is a still further object of the present invention to provide the purposes of the phthalocyanine aryl ruthenium complex.
For this purpose, technical solution provided by the invention are as follows:
A kind of phthalocyanine aryl ruthenium complex, shown in the phthalocyanine aryl ruthenium complex structural formula such as formula (I):
The preparation method of the phthalocyanine aryl ruthenium complex, includes the following steps:
1) RuCl for being 37% by ruthenium weight content3·xH2The γ-terpinene that O and purity are 95% is dissolved in dehydrated alcohol
In, it is heated to reflux stirring, precipitation is stood and obtains formula (II) compound;
2) the bromo- phthalocyanine of β-one, 5- (2- hydroxyethyl) -2- bipyridine and potassium carbonate is taken to be dissolved in DMF solution, nitrogen protection
After lower 80 DEG C of reactions, stands precipitation and obtain formula (III) compound;
3) formula (III) compound and formula (II) compound are dissolved in dehydrated alcohol, heating stirring reflux, after the reaction was completed
Solution evaporates surplus 2ml liquid, and 30ml n-hexane is added, and red crystals, as product are precipitated.
Preferably, in the phthalocyanine-aryl ruthenium compound preparation method, in step 1), dosage of each component are as follows:
The RuCl3·xH2O is 0.366g, and the γ-terpinene is 3ml, and the dehydrated alcohol is 10ml;
The mixing time that is heated to reflux is 6 hours.
Preferably, in the phthalocyanine-aryl ruthenium compound preparation method, in step 2), dosage of each component are as follows:
The bromo- phthalocyanine of β-one is 0.1g, and 5- (2- the hydroxyethyl) -2- bipyridine is 0.06g, and the potassium carbonate is 0.20g,
The DMF solution is 10ml;
It is reacted 8 hours in lower 80 DEG C of the nitrogen protection.
Preferably, in the phthalocyanine-aryl ruthenium compound preparation method, in step 3), dosage of each component are as follows:
Formula (III) compound is 30mg, and formula (II) compound is 12mg, and the dehydrated alcohol is 8ml;
The heating stirring return time is 6 hours.
The purposes of the phthalocyanine aryl ruthenium complex is prepared using the phthalocyanine aryl ruthenium complex for treating ovary
The drug of cancer.
The present invention is include at least the following beneficial effects:
Organometallic ruthenium compound of the invention can be used for preparing the drug for the treatment of cancer, can be made into injection, tablet, ball
Agent, the form use of capsule, suspending agent or emulsion.
The preparation method of organometallic ruthenium compound of the present invention is simple, and raw material is easy to get, and has advantage at low cost.
Further advantage, target and feature of the invention will be partially reflected by the following instructions, and part will also be by this
The research and practice of invention and be understood by the person skilled in the art.
Specific embodiment
The present invention will be further described in detail below with reference to the embodiments, to enable those skilled in the art referring to specification
Text can be implemented accordingly.
It should be appreciated that such as " having ", "comprising" and " comprising " term used herein do not allot one or more
The presence or addition of a other elements or combinations thereof.
Embodiment 1
A kind of phthalocyanine aryl ruthenium complex, shown in the structural formula such as formula (I) of the phthalocyanine aryl ruthenium complex:
Structural formula:
2) physicochemical property: formula (I) compound is red crystals, soluble easily in water and organic solvent, nuclear magnetic resonance spectroscopy number
According to for1H NMR:(ppm,CDCl3) δ=1.28 (6H, d, J=6.1Hz), 2.38 (3H, s), 3.95 (2H, m, J=5.9Hz),
3.15 (1H, m, J=5.9Hz), 4.35 (2H, d, J=5.9Hz), 6.70-7.90 (22H, m, J=5.8Hz), 8.42-8.60
(4H, m, J=5.7Hz).
Embodiment 2
The preparation method of formula (I) compound, comprising the following steps:
1) RuCl for being 37% by 0.366g ruthenium weight content3·xH2The γ-terpinene that O and 3ml purity is 95% is dissolved in
10ml dehydrated alcohol is heated to reflux stirring 6 hours, stands precipitation and obtains formula (II) compound.
2) the bromo- phthalocyanine of 0.1g β-one, 0.05g 5- (2- hydroxyethyl) -2- bipyridine are weighed, 0.22g potassium carbonate is dissolved in
10ml DMF solution stands precipitation and obtains formula (III) compound after nitrogen protection lower 80 DEG C of reactions 8 hours.
3) formula of 30mg (III) compound and 12mg formula (II) compound are dissolved in 8ml dehydrated alcohol, heating stirring reflux 6
Hour, solution is evaporated surplus 2ml liquid after the reaction was completed, 30ml n-hexane is added, red crystals, as product are precipitated.
Embodiment 3
Using MTT method, vitro cytotoxicity measurement is carried out.The organometallic ruthenium compound and ovum that embodiment 1 is obtained
Nest cancer A2780 cell strain is distinguished action time 72 hours, and the results are shown in Table 1.
Medium effective concentration (IC of 1 organometallic ruthenium compound of table to tumor cell line50)
Cell strain |
A2780 (is protected from light) |
A2780 (illumination) |
IC50(μmol/mL) |
8.3±1.2 |
1.0±0.1 |
Show formula of the invention (I) compounds on ovarian cancer A2780 cell by the experiment of tumor cell in vitro inhibitory activity
Strain has significant inhibiting effect, and its inhibiting effect is remarkably reinforced under visible light illumination.
It can be seen from the results above that organometallic ruthenium compound of the invention shows the change through anticancer experiment in vitro
Closing object has strong anti-tumor activity and preferable cell phototoxicity.The present invention provides to research and develop new anti-tumor drug
New thinking.
Module number and treatment scale described herein are for simplifying explanation of the invention.To phthalocyanine virtue of the invention
The application of base ruthenium complex and its preparation method and application, modifications and variations are apparent to one skilled in the art
's.
Although the embodiments of the present invention have been disclosed as above, but its is not only in the description and the implementation listed
With it can be fully applied to various fields suitable for the present invention, for those skilled in the art, can be easily
Realize other modification, therefore without departing from the general concept defined in the claims and the equivalent scope, the present invention is simultaneously unlimited
In specific details and embodiment shown and described herein.